Literature DB >> 15551677

Flushing an i.v. line: a simple but potentially costly procedure for both patient and health unit.

Karen Wotton1, Lee-Anne Gassner, Eileen Ingham.   

Abstract

This observational study investigated the intravenous (i.v.) medication administration technique of Registered Nurses (n = 47) using the injection port of a concurrent intravenous infusion. Study findings showed that the majority of nurses adhered to the most common although debatable recommended guideline in stopping the concurrent infusion and slowly administering the medication in the syringe over 3-5 minutes, prior to flushing the line quickly. Nurses failed to account for the dead space in the i.v. line when calculating the administration rate for pre and post medication flush. Similarly, the benefits of continuing the concurrent infusion when administering intravenous medication were not taken into consideration. Based upon these study findings, we recommend changes to procedural guidelines for i.v. medication.

Entities:  

Mesh:

Year:  2004        PMID: 15551677     DOI: 10.5172/conu.17.3.264

Source DB:  PubMed          Journal:  Contemp Nurse        ISSN: 1037-6178            Impact factor:   1.787


  3 in total

1.  Importance of infusion volume and pump characteristics in extended administration of ß-lactam antibiotics.

Authors:  Barbara Claus; Franky Buyle; Hugo Robays; Dirk Vogelaers
Journal:  Antimicrob Agents Chemother       Date:  2010-09-07       Impact factor: 5.191

2.  Multiple Intravenous Infusions Phase 2b: Laboratory Study.

Authors:  Sonia Pinkney; Mark Fan; Katherine Chan; Christine Koczmara; Christopher Colvin; Farzan Sasangohar; Caterina Masino; Anthony Easty; Patricia Trbovich
Journal:  Ont Health Technol Assess Ser       Date:  2014-05-01

3.  Study on the method to avoid infusion-site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells.

Authors:  Miho Yamasaki; Keisuke Oda; Takashi Ichinose; Marie Mizuguchi; Shoko Tominaga; Kei Omoda; Nobuhiro Mori; Yorinobu Maeda; Toshihiro Nishida; Teruo Murakami
Journal:  Oncol Lett       Date:  2022-09-16       Impact factor: 3.111

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.